PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Jul-2022 Top Pharma and Life Science Events in July 2022 PharmiWeb.Jobs
05-Jul-2022 DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 DFE Pharma
05-Jul-2022 Eckert & Ziegler Lowers 2022 Profit Guidance to 27 mm EUR Eckert & Ziegler Strahlen- und Medizintechnik AG
05-Jul-2022 CureVac Files Patent Infringement Lawsuit in Germany Against BioNTech CureVac
05-Jul-2022 Productive Networking Of Pharmaceutical Leaders At PHARMAP 2022 PHARMAP 2022
05-Jul-2022 AlzeCure gets abstract on new clinical study data with NeuroRestore accepted at the Alzheimer's conference AAIC AlzeCure
05-Jul-2022 Novartis Pharmaceuticals UK launches world-first health-tech investor partnership to reimagine cardiovascular care Novartis Pharmaceuticals UK
05-Jul-2022 ProteoNic Announces Licensing of its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio ProteoNic
05-Jul-2022 Destiny Pharma announces start of a new XF-73 research programme Destiny Pharma
05-Jul-2022 Defence Therapeutics Inc.:  DEFENCE’S ACCUMTM WITH ANTIBODY DRUG CONJUGATES (ADC) IN DEVELOPMENT AGAINST CANCER Defence Therapeutics Inc.
05-Jul-2022 ProteoNic Announces Licensing of its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio B3C newswire
05-Jul-2022 Evotec completes acquisition of Rigenerand Evotec SE
04-Jul-2022 ADVANZ PHARMA completes acquisition of Intercept’s business in Europe, Canada, and all other markets outside of the U.S. Advanz Pharma
04-Jul-2022 Gerresheimer AG: Gerresheimer signs new credit facility in the amount of 150 million Euro Gerresheimer AG
04-Jul-2022 Cannovum AG part of the International Expert Hearings on Cannabis Legalization Cannovum AG
04-Jul-2022 Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA
04-Jul-2022 FUSE-AI supports German pharmacies in digitization Xlife Sciences AG
04-Jul-2022 Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk Relief Therapeutics Holding SA
04-Jul-2022 SKAN Group AG closes announced increase of its stake in Aseptic Technologies SKAN AG
01-Jul-2022 Formycon Reports on Virtual Annual General Meeting 2022 Formycon AG